The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Comparing the performance of six human papillomavirus tests in a screening population
Open accessAbstract
BACKGROUND: Several new assays have been developed for high-risk HPV testing of cervical samples; we compare six HPV tests in a screening population. METHODS: Residual material from liquid-based PreservCyt samples was assayed. Four tests (Hybrid Capture 2, Cobas, Abbott and Becton-Dickinson (BD)) measured HPV DNA while two used RNA (APTIMA and NorChip). RESULTS: Positivity rates ranged from 13.4 to 16.3% for the DNA-based tests with a significantly lower positivity rate for the Abbott assay. The Gen-Probe APTIMA assay was positive in 10.3% of women, which was significantly lower than all the DNA tests; the NorChip PreTect HPV-Proofer test was much lower at 5.2%. 40 CIN2+ cases were identified, of which 19 were CIN3+. All CIN3+ cases were HPV positive by all tests except for one, which was negative by the Abbott assay and five which were negative by the NorChip test. CONCLUSION: All HPV tests except NorChip showed high sensitivity for high-grade lesions positive by cytology, suggesting co-testing is unnecessary when using HPV tests. Positivity rates in cytology-negative specimens were similar for the DNA-based tests, but lower for the APTIMA test suggesting this maintains the high sensitivity of DNA tests, but with better specificity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“as shown by multiple previous studies, the Roche Cobas 4800 assay is known for having a relatively high sensitivity compared with other HPV assays (12, 13, 17).”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cuzick, J. M., Clavel, C., Petry, K. U., Meijer, C. J. L. M., Hoyer, H., Ratnam, S., Szarewski, A., Birembaut, P. L., Kulasingam, S., Sasieni, P. D., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21955 · Cited by 1,141
Self-citationRonco, G., Rossi, P. G., Carozzi, F., Confortini, M., Palma, P. D., Mistro, A. D., Ghiringhello, B., Girlando, S., Gillio‐Tos, A., Marco, L. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70360-2 · Cited by 935
Self-citationMeijer, C. J. L. M., Berkhof, J., Castle, P. E., Hesselink, A. T., Franco, E. L., Ronco, G., Arbyn, M., Bosch, F. X., Cuzick, J., Dillner, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24010 · Cited by 692
Self-citationCuzick, J. M., Arbyn, M., Sankaranarayanan, R., Tsu, V. D., Ronco, G., Mayrand, M., Dillner, J., & Meijer, C. J. L. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.06.019 · Cited by 637
Self-citationDillner, J., Rebolj, M., Birembaut, P., Petry, K.-U., Szarewski, A., Munk, C., de Sanjose, S., Naucler, P., Lloveras, B., Kjaer, S., et al. (2008) · BMJ · doi:10.1136/bmj.a1754 · Cited by 629
Self-citationCastle, P. E., Stoler, M. H., Wright, T. C., Sharma, A., Wright, T. L., & Behrens, C. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70188-7 · Cited by 537
Rijkaart, D., Berkhof, J. H., Rozendaal, L., van Kemenade, F. J., Bulkmans, N. W. J., Heideman, D. A. M., Kenter, G. G., Cuzick, J. M., Snijders, P. J. F., & Meijer, C. J. L. M. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70296-0 · Cited by 530
Self-citationThe ATHENA human papillomavirus study: design, methods, and baseline results
Wright, T. C., Stoler, M. H., Behrens, C. M., Apple, R. J., Derion, T., & Wright, T. L. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.07.024 · Cited by 280
Szarewski, A., Ambroisine, L., Cadman, L., Austin, J., Ho, L., Terry, G., Liddle, S., Dina, R. E., McCarthy, J. E., BUCKLEY, C. H., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0508 · Cited by 227
Self-citationClinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes
Heideman, D. A. M., Hesselink, A. T., Berkhof, J. H., van Kemenade, F. J., Melchers, W. J. G., Daalmeijer, N. F., Verkuijten, M. C. G. T., Meijer, C. J. L. M., & Snijders, P. J. F. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05552-11 · Cited by 201
Flagged first, then by citations
Research works printed but not linked: 1
- LeBar W, Taylor S, Hook EW (2009) Reproducibility of the BD Viper System with XTR Technology (Extracted Mode) with PreservCyt Liquid Based Cytology Medium. Presented at 25th Clinical Virology Symposium: Daytona Beach, FL
Cited by
Sorted by citations
Items 201–211 of 211
Avian, A., Clemente, N., Mauro, E., Isidoro, E., Di Napoli, M., Dudine, S., Fabro, A. D., Morini, S., Perin, T., Giudici, F., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19785674
Winkelmann, R., Bankov, K., von der Grün, J., Cinatl, J., Wild, P. J., Vallo, S., & Demes, M. C. (2022) · Figshare · doi:10.6084/m9.figshare.19092526
Winkelmann, R., Bankov, K., von der Grün, J., Cinatl, J., Wild, P. J., Vallo, S., & Demes, M. C. (2022) · Figshare · doi:10.6084/m9.figshare.19092529
Figueiredo, D., Ribeiro, I., Penedones, A., Mendes, D., Alves, C., Marques, F. B., & da Silva, D. P. (2024) · Figshare · doi:10.6084/m9.figshare.26573887
Ibáñez, R., Mareque, M., Granados, R., Andı́a, D., García-Rojo, M., Quílez, J. C., & Oyagüez, I. (2021) · Figshare · doi:10.6084/m9.figshare.14490325
Winkelmann, R., Bankov, K., von der Grün, J., Cinatl, J., Wild, P. J., Vallo, S., & Demes, M. C. (2022) · Figshare · doi:10.6084/m9.figshare.19092535
Álvarez, A., Díaz, S., Niño, R., Medina, Y. A., Chacón, A., & Franco, A. (2026) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.4510
Eficacia y coste-efectividad de incluir el genotipado de VPH en el cribado de cáncer de cérvix
Gutiérrez-Pizarraya, A., Márquez, J. M. M., López, R. R., Blasco‐Amaro, J. A., Sánchez, F. J., García-Agua-Soler, N., González-Álvarez, M. L., & García-Ruiz, A. J. (2026) · doi:10.52766/nwdq7431
Ren, Y., Zhang, X. M., & Xu, J. (2026) · BMC Women s Health · doi:10.1186/s12905-026-04667-w
Liu, P., Liu, Z., Yang, Y., Du, B., & Zuo, H. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1952454
Metadata
- Authors
- Cuzick, J., Cadman, L., Mesher, D., Austin, J., Ashdown-Barr, L., Ho, L., Terry, G., Liddle, S., Wright, C., Lyons, D., & Szarewski, A.
- Affiliations
- Queen Mary University of London (GB)
- St Mary's Hospital (GB)
- Corresponding author
- Szarewski, A
- Venue
- British Journal of Cancer
- Published
- 2013-01-31
- Volume
- 108
- Issue
- 4
- Pages
- 908-913
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC3590662
- OpenAlex
- W2076776080
- Cited by
- 211
- References
- 23
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 11 · 2023: 15 · 2022: 19 · 2021: 15 · 2020: 17 · 2019: 12 · 2018: 16 · 2017: 12 · 2016: 19 · 2015: 33 · 2014: 18 · 2013: 11
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Queen Mary Research Online (Queen Mary University of London) (submittedVersion, cc-by-nc-sa)
- Funders
- Cancer Research UK (C8162/A10406, C569/A10404)
- Topics
- Health Sciences › Medicine › Epidemiology › Cervical Cancer and HPV Research
- Life Sciences › Immunology and Microbiology › Microbiology › Reproductive tract infections research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
- Keywords
- HPV testing, cervical cancer screening, HPV DNA test, Norchip, Hybrid Capture 2, cobas HPV test, PreservCyt, cervical intraepithelial neoplasia, sensitivity and specificity, co-testing, liquid-based cytology
- MeSH terms
- Uterine Cervical Neoplasms, Cervix Uteri, Cytodiagnosis, DNA, Viral, Female, Humans, Sensitivity and Specificity, Biomarkers, Papillomaviridae, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
